These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 37273452)
21. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy. Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197 [TBL] [Abstract][Full Text] [Related]
22. Identification of prognosis-related genes in the cervical cancer immune microenvironment. Yang L; Yang Y; Meng M; Wang W; He S; Zhao Y; Gao H; Tang W; Liu S; Lin Z; Li L; Hou Z Gene; 2021 Jan; 766():145119. PubMed ID: 32946928 [TBL] [Abstract][Full Text] [Related]
23. Mining of immunological and prognostic-related biomarker for cervical cancer based on immune cell signatures. Wang N; Nanding A; Jia X; Wang Y; Yang C; Fan J; Dong A; Zheng G; Ma J; Shi X; Yang Y Front Immunol; 2022; 13():993118. PubMed ID: 36341424 [TBL] [Abstract][Full Text] [Related]
24. Inflammatory Biomarkers as Promising Predictors of Prognosis in Cervical Cancer Patients. Domenici L; Tonacci A; Aretini P; Garibaldi S; Perutelli A; Bottone P; Muzii L; Benedetti Panici P Oncology; 2021; 99(9):571-579. PubMed ID: 34265768 [TBL] [Abstract][Full Text] [Related]
25. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers. Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L Front Immunol; 2019; 10():6. PubMed ID: 30761122 [No Abstract] [Full Text] [Related]
26. Protein tyrosine phosphatase, receptor type B is a potential biomarker and facilitates cervical cancer metastasis via epithelial-mesenchymal transition. Huang ZY; Liao PJ; Liu YX; Zhong M; Sun AH; Jiang XC; Wang XP; Zhang M Bioengineered; 2021 Dec; 12(1):5739-5748. PubMed ID: 34516350 [TBL] [Abstract][Full Text] [Related]
27. Comprehensive Identification of the Human Secretome as Potential Indicators in Treatment Outcome of HPV-Positive and -Negative Cervical Cancer Patients. Kong L; Wang J; Cheng J; Zang C; Chen F; Wang W; Zhao H; Wang Y; Wang D Gynecol Obstet Invest; 2020; 85(5):405-415. PubMed ID: 33171469 [TBL] [Abstract][Full Text] [Related]
28. Correlation of INHBA Overexpression with Pathological Features, Antitumor Immune Response and Clinical Prognosis in Cervical Cancer. Zeng L; Sun X Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984496 [No Abstract] [Full Text] [Related]
29. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y Front Immunol; 2023; 14():1155182. PubMed ID: 37275857 [TBL] [Abstract][Full Text] [Related]
30. CDK12 Promotes Cervical Cancer Progression through Enhancing Macrophage Infiltration. Yang B; Chen J; Teng Y J Immunol Res; 2021; 2021():6645885. PubMed ID: 33628849 [TBL] [Abstract][Full Text] [Related]
31. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification. Sun K; Huang C; Li JZ; Luo ZX World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777 [TBL] [Abstract][Full Text] [Related]
32. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma. Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269 [TBL] [Abstract][Full Text] [Related]
33. High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer. Liu S; Meng F; Ding J; Ji H; Lin M; Zhu J; Ma R Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30792262 [TBL] [Abstract][Full Text] [Related]
34. TMEM33: a new stress-inducible endoplasmic reticulum transmembrane protein and modulator of the unfolded protein response signaling. Sakabe I; Hu R; Jin L; Clarke R; Kasid UN Breast Cancer Res Treat; 2015 Sep; 153(2):285-97. PubMed ID: 26268696 [TBL] [Abstract][Full Text] [Related]
35. Identification of miRNA-mRNA Regulatory Network and Construction of Prognostic Signature in Cervical Cancer. Mei Y; Jiang P; Shen N; Fu S; Zhang J DNA Cell Biol; 2020 Jun; 39(6):1023-1040. PubMed ID: 32349536 [TBL] [Abstract][Full Text] [Related]
36. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma. Zhang M; Liu Y; Hou S; Wang Y; Wang C; Yin Y; Chen X Mol Omics; 2022 Jul; 18(6):506-519. PubMed ID: 35485290 [TBL] [Abstract][Full Text] [Related]
37. Screening of cervical cancer-related hub genes based on comprehensive bioinformatics analysis. Tu S; Zhang H; Yang X; Wen W; Song K; Yu X; Qu X Cancer Biomark; 2021; 32(3):303-315. PubMed ID: 34151839 [TBL] [Abstract][Full Text] [Related]
38. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types. Guo B; Wang Y; Liu W; Zhang S Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654 [TBL] [Abstract][Full Text] [Related]
39. Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways. Xu Q; Chen C; Liu B; Lin Y; Zheng P; Zhou D; Xie Y; Lin Y; Guo C; Liu J; Li L Oncol Rep; 2020 Jan; 43(1):41-54. PubMed ID: 31661139 [TBL] [Abstract][Full Text] [Related]
40. High expression of flotillin-2 is associated with poor clinical survival in cervical carcinoma. Liu Y; Lin L; Huang Z; Ji B; Mei S; Lin Y; Shen Z Int J Clin Exp Pathol; 2015; 8(1):622-8. PubMed ID: 25755754 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]